SCHEMBL9508650

SCHEMBL9508650

CC(C)(C)c1ccc2c(C(O[SiH3])(c3ccccc3)c3ccccc3)c(CO)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.34
CYP2D6 P10635 2/20 0.33
GPR84 Q9NQS5 1/20 0.33
NR1I2 O75469 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
MAPK14 Q16539 1/20 0.30
KLF10 Q13118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9080434 0.88 NR1I2 (0.32) KIF11CYP2D6NR1I2
SCHEMBL9701313 0.70 CYP2D6 (0.35) KIF11CYP2D6GPR84NR1I2MEN1
SCHEMBL9967889 0.67 HSD17B10 (0.41) ALDH1A1CYP1A2CYP2C19HSD17B10
SCHEMBL10409091 0.67 ALDH1A1 (0.54) KIF11CYP2D6NR1I2MEN1POLB
SCHEMBL19798852 0.66 CYP2D6 (0.42) KIF11CYP2D6GPR84NR1I2MEN1
SCHEMBL15066839 0.64 PTPN1 (0.41) KIF11CYP2D6ALDH1A1CYP1A2HSD17B10
SCHEMBL9138077 0.64 CYP2D6 (0.33) KIF11CYP2D6MEN1GAAKMT2A
SCHEMBL6044383 0.64 MRGPRX4 (0.49)
SCHEMBL8954235 0.64 ALDH1A1 (0.33) KIF11CYP2D6ALDH1A1CYP1A2CYP2C19
SCHEMBL22275799 0.63 KLF10 (0.53) KIF11CYP2D6MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550566-A1 ANTIPROLIFERATIVE SUBSTITUTED NAPHTHALENE COMPOUNDS AGOURON PHARMACEUTICALS (US) 1993-07-14 EP disclosed
WO-1992005153-A1 ANTIPROLIFERATIVE SUBSTITUTED NAPHTHALENE COMPOUNDS AGOURON PHARMACEUTICALS, INC. (US) 1992-04-02 WO disclosed